期刊文献+

松弛素对高糖环境下肾小球系膜细胞分泌细胞外基质的影响及其作用机制研究

Study of the effect and mechanism of relaxin on the ECM excretion of Human renal mesangial cells cultured in high ambient glucose
原文传递
导出
摘要 目的 观察人松弛素(RLX)对高糖培养人肾小球系膜细胞分泌细胞外基质的影响,初步探讨其可能作用机制.方法 将人肾小球系膜细胞株分组:正常糖组:含5.5 mmol/L葡萄糖;高糖组:含30 mmol/L葡萄糖;松弛素干预组:高糖(30 mmol/L葡萄糖)+松弛素(10 ng/ml);α-平滑肌动蛋白(α-SMA)的检测增加TGF-β1阳性对照组,即5.5 mmol/L葡萄糖+TGF-β1(5μg/L).CCK-8法检测松弛素对系膜细胞增殖的影响,ELISA法检测细胞上清中Ⅳ型胶原(ColⅣ)、纤连蛋白(FN)的表达.qPCR检测系膜细胞TGF-β1 mRNA表达.免疫印迹技术(Western blot)检测α-SMA表达,确定肾小球系膜细胞表型转化情况.结果 松弛素对正常糖组及高糖组系膜细胞活力均未发现有影响;与正常糖组相比,高糖组各时间点肾系膜细胞分泌ColⅣ、FN显著增加,48 h尤为明显(57.28±0.59 vs 41.85 ±0.03、56.52±0.88 vs 33.80±0.24,P<0.01),α-SMA表达增加(P<0.05).与高糖组比较,松弛素干预组ColⅣ、FN表达在48 h下降最为明显(47.08±0.03 vs 57.28±0.59、36.16±0.52 vs 56.52±0.88,P<0.01),α-SMA表达减少(P<0.01),TGF-β1 mRNA表达下降(P<0.01).结论 松弛素能抑制高糖培养的系膜细胞分泌细胞外基质,部分作用机制是通过抑制细胞表型转分化及抑制TGF-β1基因表达,具有抗纤维化作用. Objective To explore the effect and mechanism of relaxin on the production of extracellular matrix (ECM) excreted by high glucose stimulated human renal mesangial cells.Methods Cultured human mesangial cells (HMCs) were divided into three groups:(1) normal glucose group (NG,5.5 mmol/L D-glucose),(2) high glucose group (HG,30 mmol/L D-glucose),and (3) high glucose + relaxin group.Cell count kit (CCK8) was used to examine the cell proliferation.The levels of fibronectin and collagen type Ⅳ in the culture supernatants were examined with a solid-phase enzyme-linked immunoadsorbent assay (ELISA);Western blot method was used to detect the expression of α-smooth muscle actin (α-SMA) protein.The transforming growth factor-β1 (TGF-β1) mRNA expression was detected with quantitative polymerase chain reaction (qPCR) method.Results No proliferation and inhibition effects were observed in both normal and high glucose group.Compared to the normal glucose group,the levels of fibronectin,and collagen type Ⅳ increased significantly (57.28 ± 0.59 vs 41.85 ± 0.03,56.52 ± 0.88 vs 33.80 ± 0.24,P 〈 0.01)after cultured 48 h in high concentration of glucose.Compared to the high glucose group,a significantly decreases of fibronectin and collagen type Ⅳ (47.08 ± 0.03 vs 57.28 ± 0.59,36.16 ± 0.52 vs 56.52 ±0.88,P 〈0.01) were observed in the relaxin treated group.The expressions of α-smooth muscle actin and TGF-β1 were decreased (P 〈0.01).Conclusions Relaxin can suppress the overproduction of ECM excreted by HMC cultured in high ambient glucose,and its mechanism is partly due to the inhibition of TGF-β1.
出处 《中国医师杂志》 CAS 2015年第4期537-540,544,共5页 Journal of Chinese Physician
基金 杭州市科技局重点专病资助项目(20100733Q06)
关键词 松弛素/药理学 葡萄糖/投药和剂量 肾小球系膜细胞/代谢/药物作用 细胞外基质/药物作用 转化生长因子β1/代谢 肌动蛋白类/代谢 胶原Ⅳ型/代谢 纤连蛋白类/代谢 Relaxin/PD Glucose/AD Mesangial cells/ME/DE Extracellular matrix/DE Transforming growth factor beta1/ME Actins/ME Collagen type Ⅳ/ME Fibronectins/ME
  • 相关文献

参考文献16

  • 1中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中国糖尿病杂志,2014,22(8). 被引量:6731
  • 2Tomino Y. Pathogenesis and treatment of chronic kidney disease: a review of our recent basic and clinical data [ J ]. Kidney Blood Press Res,2014,39(5 ) :450-489.
  • 3Pugliese G. Updating the natural history of diabetic nephropathy [J]. Acta Diabetol,2014,51 (6) :905-915.
  • 4Qian Y, Feldman E, Pennathur S, et al. From fibrosis to sclero- sis : mechanisms of glomerulosclerosis in diabetic nephropathy [ J ]. Diabetes ,2008,57 ( 6 ) : 1439-1445.
  • 5Abdallab S, Ahmad AT, Batieha A, et al. Diabetes mellitus: the leading cause of haemodialysis in Jordan[ J]. East Mediterr Health J,2007,13 ( 4 ) :803-809.
  • 6周素娴,雷闽湘,赵晋晋.高糖对系膜细胞产生纤维联接蛋白、Ⅳ型胶原及PAF的影响[J].中国医师杂志,2009,11(8):1024-1026. 被引量:1
  • 7Garud MS, Kulkarni YA. Hyperglycemia to nephropathy via trans- forming growth factor beta[ J]. Curr Diabetes Rev,2014, 10 ( 3 ) : 182-189.
  • 8Heeg MH, Koziolek MJ, Vasko R, et al. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibi- tion of the Smad2 pathway[ J]. Kidney Int,2005,68 (1) :96-109.
  • 9Park JI, Chang CL, Hsu SY. New Insights into biological roles of relaxin and relaxin-related peptides [ J ]. Rev Endocr Metab Dis- ord,2005,6(4) :291-296.
  • 10Samuel CS, Hewitson TD, Unemori EN, et al. Drugs of the fu- ture: the hormone relaxin[ J]. Cell Mol Life Sci,2007,64(12) : 1539-1557.

二级参考文献6

  • 1Marques SA, Dy LC, Southall MD,et al. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitegenactivated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. J Pharmaeol Exp Ther, 2002, 300 ( 3 ) : 1026-1035.
  • 2Ikeda O, Egami H, lshiko T, et al. Expression of proteinase-aetivated receptor in human pancteatic cancer: a possible relation to cancer invasion and induction of fibrosis. Int J Oncol, 2003,22 ( 2 ) : 295- 300.
  • 3Kikuchi M, Shirasaki H, Himi T. Platelet-activating factor (PAF) increases NO production in human endothelial cells-real-time monitoring by DAR-4M AM. Prostaglandins Leukot Essent Fatty Acids, 2008,78 (4-5) :305-309.
  • 4Jocks T, Freudenberg J, Zahner G, et al. Platelet-activating factor mediates monocyte chemoattractant protein-1 expression in glomerular immune injury. Nephrol Dial Transplant, 1998,13( 1 ) :37-43.
  • 5Lindschau C, Quass P, Menne J, et al. Glucose-induced TGF-betal and TGF-beta receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-alpha. Hypertension,2003,42 (3) :335- 341.
  • 6Zheng .IM, Zhu JM, Li LS, Liu ZH . Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway. Br J Pharmacol, 2008,153 (7) : 1456-1464.

共引文献6730

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部